The role of TRPM8 in susceptibility to highly pathogenic avian influenza A/H5N1

TRPM8在高致病性禽流感A/H5N1易感性中的作用

基本信息

  • 批准号:
    MR/L008599/1
  • 负责人:
  • 金额:
    $ 35.55万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2014
  • 资助国家:
    英国
  • 起止时间:
    2014 至 无数据
  • 项目状态:
    已结题

项目摘要

In the last decade an animal influenza A virus has crossed the species barrier and caused an appreciable number of human cases on five occasions. Highly pathogenic avian influenza A(H5N1) has resulted in very rare episodes of limited person-to-person transmission but has not adapted to humans. Another avian influenza virus (H7N7) caused a large number of, mostly mild, human infections in the Netherlands in 2003 and also demonstrated some ability for limited person-to-person transmission, but was successfully controlled by extensive culling of poultry flocks. The swine H1N1 influenza virus that emerged in 2009 successfully adapted to humans, caused a pandemic, and is now firmly established as a human influenza virus. Another swine-origin virus (H3N2v) has been transmitted occasionally from pigs to humans in the U.S. since 2011 but has not managed to switch hosts and become established in the human population. The ongoing avian influenza A(H7N9) outbreak that was first detected in China in February 2013 has caused more than 130 human cases at the time of writing, and shows some evidence of adaptation to humans. A central question that arises when an animal influenza virus crosses the species barrier and infects humans is the probability that the virus will adapt to humans and cause a pandemic. Despite much research, the barriers that must be overcome for animal influenza viruses to stably adapt to humans are still not fully understood. Assessing the public health threat of H5N1 and other animal influenza viruses requires a fuller understanding of what currently constrains the ability of animal influenza viruses to infect humans and to transmit between humans. The characteristics of influenza viruses that are associated with adaptation to humans have been studied in detail. However, the human-host characteristics are much less well studied. Around one third of all human H5N1 cases have occurred in clusters, and 50 of the 54 H5N1 clusters reported as of March 2009 were comprised entirely of blood relatives. We and other authors have concluded that this familial clustering and other aspects of the epidemiology of H5N1 suggest a role for host genetic factors.To test our hypothesis that host genetic factors may play an important role in restricting susceptibility to H5N1, we conducted a study to look for human genetic factors that might be associated with an increased risk of getting H5N1 infection. We studied 65 people with H5N1 infection (cases) and 2,910 people without H5N1 infection (controls) and found a variant in one particular gene (TRPM8) that was more common in cases compared to controls. We went on to study the effect of this gene on H5N1 infection in cells in the laboratory and in mice. We found that this gene did indeed affect the ability of the H5N1 virus to replicate in cells and to cause disease in mice. The aim of this new research is to futher determine and characterize the role of the TRPM8 gene in susceptibility to infection with H5N1. We will do this by (1) gathering samples and analysing the genetic code from human H5N1 cases in Indonesia to test if the genetic variant is also present this independent set of samples, (2) fully sequencing the whole TRPM8 gene in cases and controls to identify precisely which genetic variations may be responsible, (3) exploring how different influenza viruses bind to the protein produced by the TRPM8 gene, and (4) further assessing the role of TRMP8 in H5N1 infection in mice.This research is important since the results will provide new information on the adaptations necessary for animal influenza viruses to succesfully infect humans and may also provide a new target for drugs to prevent or treat influenza infections.
在过去十年中,一种动物甲型流感病毒跨越了物种障碍,在五个场合造成了相当数量的人类病例。高致病性禽流感A(H5 N1)导致非常罕见的有限人际传播,但尚未适应人类。2003年,另一种禽流感病毒(H7 N7)在荷兰造成了大量的人感染,其中大多数是轻度的,也显示出一定的有限人际传播能力,但通过广泛扑杀家禽群成功地控制了这种病毒。2009年出现的猪H1N1流感病毒成功地适应了人类,引起了大流行,现在已经确定为人类流感病毒。自2011年以来,另一种猪源性病毒(H3 N2 v)偶尔在美国从猪传播给人类,但尚未成功转换宿主并在人群中建立。2013年2月首次在中国发现的持续的甲型H7N9禽流感疫情在撰写本报告时已造成130多例人间病例,并显示出一些适应人类的证据。当动物流感病毒跨越物种屏障感染人类时,出现的一个中心问题是病毒适应人类并引起大流行的可能性。尽管进行了大量研究,但动物流感病毒稳定适应人类所必须克服的障碍仍然没有完全了解。评估H5 N1和其他动物流感病毒对公共卫生的威胁需要更全面地了解目前是什么限制了动物流感病毒感染人类和在人类之间传播的能力。与适应人类有关的流感病毒的特征已被详细研究。然而,人-宿主特性的研究要少得多。在所有人类H5 N1病例中,约有三分之一发生在集群中,截至2009年3月报告的54个H5 N1集群中有50个完全由血亲组成。我们和其他作者的结论是,这种家族聚集性和H5 N1流行病学的其他方面表明宿主遗传因素的作用。为了验证我们的假设,即宿主遗传因素可能在限制对H5 N1的易感性方面发挥重要作用,我们进行了一项研究,以寻找可能与H5 N1感染风险增加相关的人类遗传因素。我们研究了65名H5 N1感染者(病例)和2,910名未感染H5 N1的人(对照组),发现一种特定基因(TRPM 8)的变异在病例中比对照组更常见。我们接着在实验室细胞和小鼠中研究了这种基因对H5 N1感染的影响。我们发现,这个基因确实影响了H5 N1病毒在细胞中复制的能力,并在小鼠中引起疾病。这项新研究的目的是进一步确定和表征TRPM 8基因在H5 N1感染易感性中的作用。我们将通过以下方式做到这一点:(1)收集印度尼西亚人类H5 N1病例的样本并分析遗传密码,以测试遗传变异是否也存在于这一独立样本组中,(2)对病例和对照组中的整个TRPM 8基因进行全面测序,以准确确定哪些遗传变异可能是原因,(3)探索不同的流感病毒如何与TRPM 8基因产生的蛋白质结合,(4)进一步评估TRMP 8在小鼠感染H5 N1中的作用,该研究结果将为动物流感病毒成功感染人类所需的适应性提供新的信息,也可能为预防或治疗流感感染的药物提供新的靶点,因此具有重要意义。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Horby其他文献

Improving clinical care of patients in Nipah outbreaks: moving beyond ‘compassionate use’
改善尼帕病毒爆发期间患者的临床护理:超越“同情用药”
  • DOI:
    10.1016/j.lansea.2024.100527
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
    6.200
  • 作者:
    Md Zakiul Hassan;Amanda Rojek;Piero Olliaro;Peter Horby
  • 通讯作者:
    Peter Horby
Ebola disease: bridging scientific discoveries and clinical application
埃博拉病:连接科学发现与临床应用
  • DOI:
    10.1016/s1473-3099(24)00673-x
  • 发表时间:
    2025-03-01
  • 期刊:
  • 影响因子:
    31.000
  • 作者:
    Amanda Rojek;Joshua Fieggen;Paska Apiyo;Séverine Caluwaerts;Robert A Fowler;Pontiano Kaleebu;Richard Kojan;Marta Lado;Teresa Lambe;Jake Dunning;Peter Horby
  • 通讯作者:
    Peter Horby
Embedding treatment in stronger care systems
将治疗嵌入更强大的护理体系中
  • DOI:
    10.1016/s1473-3099(24)00727-8
  • 发表时间:
    2025-03-01
  • 期刊:
  • 影响因子:
    31.000
  • 作者:
    Amanda Rojek;Joshua Fieggen;Amy Paterson;Pauline Byakika-Kibwika;Modet Camara;Kim Comer;Tom E Fletcher;Stephan Günther;Sylvie Jonckheere;Gerald Mwima;Jake Dunning;Peter Horby
  • 通讯作者:
    Peter Horby
A multi-country analysis of COVID-19 hospitalizations by vaccination status
  • DOI:
    10.1016/j.medj.2023.08.005
  • 发表时间:
    2023-11-10
  • 期刊:
  • 影响因子:
  • 作者:
    Bronner P. Gonçalves;Waasila Jassat;Joaquín Baruch;Madiha Hashmi;Amanda Rojek;Abhishek Dasgupta;Ignacio Martin-Loeches;Luis Felipe Reyes;Chiara Piubelli;Barbara Wanjiru Citarella;Christiana Kartsonaki;Benjamin Lefèvre;José W. López Revilla;Miles Lunn;Ewen M. Harrison;Moritz U.G. Kraemer;Sally Shrapnel;Peter Horby;Zeno Bisoffi;Piero L. Olliaro
  • 通讯作者:
    Piero L. Olliaro
Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England
  • DOI:
    10.1186/s13063-024-08273-9
  • 发表时间:
    2024-06-29
  • 期刊:
  • 影响因子:
    2.000
  • 作者:
    Guilherme Pessoa-Amorim;Raphael Goldacre;Charles Crichton;Will Stevens;Michelle Nunn;Andy King;Dave Murray;Richard Welsh;Heather Pinches;Andrew Rees;Eva J. A. Morris;Martin J. Landray;Richard Haynes;Peter Horby;Karl Wallendszus;Leon Peto;Mark Campbell;Charlie Harper;Marion Mafham
  • 通讯作者:
    Marion Mafham

Peter Horby的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Horby', 18)}}的其他基金

COVID-19: multi-arm, multi stage adaptive clinical trial (CoV-MAMS)
COVID-19:多组、多阶段适应性临床试验(CoV-MAMS)
  • 批准号:
    MC_PC_19056
  • 财政年份:
    2020
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Intramural

相似国自然基金

宫颈上皮细胞TRPM8介导CD11chigh巨噬细胞扩增在自发性早产宫颈过早成熟的作用机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
活化FFAR4构建TRPM8通道低活性脱敏态对慢阻肺气道黏液冷刺激性高分泌的遏制效应研究
  • 批准号:
    82300054
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
电针通过PKC信号通路调控TRPM8治疗干眼的机制研究
  • 批准号:
    22ZR1458500
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
常温携氧机械灌注通过TRPM8/ACSL1调控线粒体功能改善脂肪供肝质量的机制研究
  • 批准号:
    82200734
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
长爪沙鼠帕金森病模型体系的建立及TRPM8的神经保护作用与分子机制
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
缺失Mdm2的骨细胞通过凋亡小体激活成骨细胞内TRPM8通道调控颌骨骨形成和改建的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
肠道AKK 菌代谢短链脂肪酸调控TRPM8 转录增强胰腺癌吉西他滨敏感性的机制研究
  • 批准号:
    2022JJ30626
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
cGMP调控TRPM8介导钙内流与肺动脉高压发病和干预机制的研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
TRPM8 离子通道小分子抑制剂筛选及其调控机制研究
  • 批准号:
    2021JJ30479
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
动物TRPM8受体低温敏感功能的获得机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

炎症による細胞機能低下に対するTRPM8活性化冷却刺激の影響
冷却刺激对 TRPM8 激活对炎症诱导的细胞功能下降的影响
  • 批准号:
    24K14337
  • 财政年份:
    2024
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
選択的TRPM8阻害薬を用いた慢性前立腺炎/骨盤痛症候群の新規治療法の開発
使用选择性 TRPM8 抑制剂开发慢性前列腺炎/盆腔疼痛综合征的新疗法
  • 批准号:
    24K19681
  • 财政年份:
    2024
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
低温による消化管蠕動抑制とTRPM8チャネルおよび過敏性腸症候群の関連
低温引起的胃肠蠕动抑制、TRPM8通道与肠易激综合征的关系
  • 批准号:
    24K18990
  • 财政年份:
    2024
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Resolving the Molecular Bases for Activation and Regulation in the Cold Receptor TRPM8
解析冷受体 TRPM8 激活和调节的分子基础
  • 批准号:
    557364-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
TRPM8チャネルとカハール介在細胞による消化管蠕動制御の検討および臨床応用
TRPM8通道和Cajal介导细胞控制胃肠蠕动的研究及临床应用
  • 批准号:
    22K20899
  • 财政年份:
    2022
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Molecular Mechanisms and Regulation Networks of TRPM8
TRPM8的分子机制和调控网络
  • 批准号:
    10396096
  • 财政年份:
    2021
  • 资助金额:
    $ 35.55万
  • 项目类别:
Resolving the Molecular Bases for Activation and Regulation in the Cold Receptor TRPM8
解析冷受体 TRPM8 激活和调节的分子基础
  • 批准号:
    557364-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Efficacy of temperature-sensitive TRPM8 channels in refractory epilepsy and the elucidation of pathogenetic regulation
温度敏感TRPM8通道在难治性癫痫中的功效及发病机制的阐明
  • 批准号:
    21K15269
  • 财政年份:
    2021
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer
评估表达 TRPM8 的神经元作为头颈癌患者急性放疗相关疼痛的新调节因子
  • 批准号:
    10361425
  • 财政年份:
    2021
  • 资助金额:
    $ 35.55万
  • 项目类别:
Molecular Mechanisms and Regulation Networks of TRPM8
TRPM8的分子机制和调控网络
  • 批准号:
    10795242
  • 财政年份:
    2021
  • 资助金额:
    $ 35.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了